The myelodysplastic syndrome refers to a group of disorders in which the blood cells in the bone marrow remain immature and do not convert into healthy blood cells. The cause of some diseases is unknown, but for others, it may be due to a response to cancer therapy. Symptoms include fatigue, shortness of breath, paleness, and easy bruising. Treatment involves managing the symptoms with medication and blood transfusions.
Transfusion-Dependent Low-Risk Myelodysplastic Syndromes
Transfusion-dependent low-risk MDS is managed through blood transfusions to relieve symptoms from low blood cell counts.
Lenalidomide for Myelodysplastic Syndromes - Dose, Pharmacology, Side-Effects, and Contraindications
Lenalidomide is used for the treatment of transfusion-dependent anemia resulting from low-risk myelodysplastic syndromes. Read further to know more.
Diagnostic Challenges in Myelodysplastic Syndromes
Diagnosing myelodysplastic syndromes is complex, with challenges in symptoms, genetic variability, and evolving classification criteria.
Vaccine Therapy for Myelodysplastic Syndrome
Myelodysplastic neoplasms are clonal hematopoietic malignancies usually observed in older individuals; for more information, read further.
Myelodysplasia in Children - Understanding a Rare Blood Disorder
Myelodysplastic syndrome in children is a group of rare diseases in which the bone marrow does not make healthy blood cells. For more details, read below.
Myelodysplastic Syndrome of Bone Marrow - An Overview
Myelodysplastic syndromes are disorders of poorly formed blood cells or non-functional blood cells. Continue reading to know more.
Decitabine - Uses, Side Effects, Pharmacology, and Toxicity
Decitabine is used to treat Myelodysplastic syndrome. Read below to get into detail about the same.
Rheumatic Manifestations of Myelodysplastic Syndromes
Myelodysplastic syndromes (MDS) develop when the blood-forming cells in the bone marrow become abnormal.
